Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activated platelets are blood cell fragments that have undergone a transformation in response to vascular injury or other stimuli, shifting from a resting state to an active one. This activation is central to hemostasis (the process of stopping bleeding), thrombosis (clot formation), inflammation, and immune responses. They initiate and propagate clot formation by adhering to damaged blood vessels and aggregating, release granule contents to recruit more platelets, and contribute to wound healing and inflammation.
Inhibition of platelet activation pathways (e.g., COX-1 inhibition, P2Y12 receptor blockade)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activated Platelet.